Abstract
Computer-aided drug design (CADD) methodologies have proven to be very effective, greatly enhancing the efficiency of small molecule drug discovery and development processes. These methods include quantitative structureactivity relationship and pharmacophore models, quantitative structure-property relationship models, as well as in silico docking studies. While docking studies very often correctly identify the binding mode of a ligand, they have reduced success in predicting binding affinities. Development of improved and more efficient strategies for scoring binding affinity is a very active area of research. Here we review the utility of computational intelligence approaches such as artificial neural networks, fuzzy logic, and evolutionary computation to the calculation of improved docking scores.
Keywords: Computational intelligence, evolutionary algorithms, artificial neural networks, fuzzy logic, docking scores, in silico docking, high-throughput screening, virtual screening
Current Computer-Aided Drug Design
Title: Computational Intelligence Methods for Docking Scores
Volume: 5 Issue: 1
Author(s): David Hecht and Gary B. Fogel
Affiliation:
Keywords: Computational intelligence, evolutionary algorithms, artificial neural networks, fuzzy logic, docking scores, in silico docking, high-throughput screening, virtual screening
Abstract: Computer-aided drug design (CADD) methodologies have proven to be very effective, greatly enhancing the efficiency of small molecule drug discovery and development processes. These methods include quantitative structureactivity relationship and pharmacophore models, quantitative structure-property relationship models, as well as in silico docking studies. While docking studies very often correctly identify the binding mode of a ligand, they have reduced success in predicting binding affinities. Development of improved and more efficient strategies for scoring binding affinity is a very active area of research. Here we review the utility of computational intelligence approaches such as artificial neural networks, fuzzy logic, and evolutionary computation to the calculation of improved docking scores.
Export Options
About this article
Cite this article as:
Hecht David and Fogel B. Gary, Computational Intelligence Methods for Docking Scores, Current Computer-Aided Drug Design 2009; 5 (1) . https://dx.doi.org/10.2174/157340909787580863
DOI https://dx.doi.org/10.2174/157340909787580863 |
Print ISSN 1573-4099 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6697 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Structural Insights Into Bioactive Thiazolidin-4-one: Experimental and Theoretical Data
Letters in Organic Chemistry Synthesis, Molecular Docking and Pharmacological Study of Pyrimidothiadiazinones and its bis-derivatives
Letters in Drug Design & Discovery Fibrinogen, Fibrin, and Fibrin Degradation Products in COVID-19
Current Drug Targets Statistical Molecular Design of Balanced Compound Libraries for QSAR Modeling
Current Medicinal Chemistry Small Molecule and Biologic Inhibitors of Hepatitis C Virus: A Symbiotic Approach
Mini-Reviews in Medicinal Chemistry Inhibitors of the Proteolytic Activity of Urokinase Type Plasminogen Activator
Current Pharmaceutical Design Impact of Drug Metabolism/Pharmacokinetics and their Relevance Upon Taxus-based Drug Development
Current Drug Metabolism Phytochemical Constituents, ChEs and Urease Inhibitions, Antiproliferative and Antioxidant Properties of Elaeagnus umbellata Thunb.
Combinatorial Chemistry & High Throughput Screening Sulfur-Containing Compounds in Protecting Against Oxidant-Mediated Lung Diseases
Current Medicinal Chemistry COVID-19 Biomarkers Recognition & Classification Using Intelligent Systems
Current Bioinformatics Anti-Inflammatory and Anti-Allergy Drugs in Rhinosinusitis
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Use of Natural Compounds as a Potential Therapeutic Agent Against COVID-19
Current Pharmaceutical Design Current Inhibitors of Checkpoint Kinase 2
Current Medicinal Chemistry Human A3 Adenosine Receptor as Versatile G Protein-Coupled Receptor Example to Validate the Receptor Homology Modeling Technology
Current Pharmaceutical Design The Impact of Combinatorial Methodologies on Medicinal Chemistry
Current Topics in Medicinal Chemistry Herbal Natural Products As a Source of Monoamine Oxidase Inhibitors: A Review
Current Topics in Medicinal Chemistry α-N-Heterocyclic Thiosemicarbazone Derivatives as Potential Antitumor Agents: A Structure-Activity Relationships Approach
Mini-Reviews in Medicinal Chemistry Antiviral Treatment of Chikungunya Virus Infection
Infectious Disorders - Drug Targets Therapeutic Role of Phytophenol Gallic Acid for the Cure of COVID-19 Pathogenesis
Endocrine, Metabolic & Immune Disorders - Drug Targets Computational Methods to Predict Drug Safety
Current Computer-Aided Drug Design